| Herb | Conventional drug | Potential problem |
|---|---|---|
| Echinacea used for >8 weeks | Anabolic steroids, methotrexate, amiodarone, ketoconazole | Hepatotoxicity |
| Feverfew | Non-steroidal anti-inflammatory drugs | Inhibition of herbal effect |
| Feverfew, garlic, ginseng, gingko, ginger | Warfarin | Altered bleeding time |
| Ginseng | Phenelzine sulphate | Headache, tremulousness, manic episodes |
| Ginseng | Oestrogens, corticosteroids | Additive effects |
| St John’s wort | Monoamine oxidase inhibitor and serotonin reuptake inhibitor antidepressants | Mechanism of herbal effect uncertain. Insufficient evidence of safety with concomitant use—therefore not advised |
| Valerian | Barbiturates | Additive effects, excessive sedation |
| Kyushin, liquorice, plantain, uzara root, hawthorn, ginseng | Digoxin | Interference with pharmacodynamics and drug level monitoring |
| Evening primrose oil, borage | Anticonvulsants | Lowered seizure threshold |
| Shankapulshpi (Ayurvedic preparation) | Phenytoin | Reduced drug levels, inhibition of drug effect |
| Kava | Benzodiazepines | Additive sedative effects, coma |
| Echinacea, zinc (immunostimulants) | Immunosuppressants (such as corticosteroids, cyclosporin) | Antagonistic effects |
| St John’s wort, saw palmetto | Iron | Tannic acid content of herbs may limit iron absorption |
| Kelp | Thyroxine | Iodine content of herb may interfere with thyroid replacement |
| Liquorice | Spironolactone | Antagonism of diuretic effect |
| Karela, ginseng | Insulin, sulphonylureas, biguanides | Altered glucose concentrations. These herbs should not be prescribed in diabetic patients |